MHRA (UK)Original article
Guidance: 14-day assessment stepwise implementation programme for Phase 1 clinical trials
RegulatoryPositive
AI Analysis
Summary
The MHRA has issued guidance on a stepwise implementation programme to deliver regulatory assessments for Phase 1 clinical trials within 14 calendar days for qualifying applications by end of 2026.
Clinical Trial Data
Phase
Phase 1
Importance:3/10
Sentiment:
0.50
MHRAPhase 1regulatory guidanceassessment timelineUK
Related Companies
Read the original article
Published by MHRA (UK) on September 30, 2026 2:32 PM